ARTICLE | Company News
FDA approves Genzyme's Cerdelga
August 20, 2014 1:47 AM UTC
FDA approved Cerdelga eliglustat from the Genzyme Corp. unit of Sanofi (Euronext:SAN; NYSE:SNY) to treat Type I Gaucher's disease. The product is also under review in Europe for the indication. Genzym...